NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 184 filers reported holding NEKTAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $9,001,000 | -3.8% | 733,599 | +34.6% | 0.01% | -16.7% |
| Q3 2016 | $9,361,000 | +14.7% | 544,904 | -5.0% | 0.01% | +20.0% |
| Q2 2016 | $8,160,000 | -9.2% | 573,469 | -12.2% | 0.01% | -16.7% |
| Q1 2016 | $8,983,000 | -16.3% | 653,281 | +2.6% | 0.01% | -14.3% |
| Q4 2015 | $10,731,000 | +55.8% | 636,866 | +1.3% | 0.01% | +55.6% |
| Q3 2015 | $6,888,000 | -4.8% | 628,436 | +8.7% | 0.01% | 0.0% |
| Q2 2015 | $7,235,000 | +75.9% | 578,311 | +54.7% | 0.01% | +80.0% |
| Q1 2015 | $4,113,000 | -28.7% | 373,919 | +0.5% | 0.01% | -37.5% |
| Q4 2014 | $5,769,000 | +28.8% | 372,193 | +0.3% | 0.01% | +33.3% |
| Q3 2014 | $4,479,000 | -5.3% | 371,110 | +0.6% | 0.01% | 0.0% |
| Q2 2014 | $4,728,000 | +5.4% | 368,788 | -0.3% | 0.01% | -14.3% |
| Q1 2014 | $4,485,000 | +16.0% | 370,060 | +8.7% | 0.01% | +16.7% |
| Q4 2013 | $3,865,000 | +6.2% | 340,493 | -2.3% | 0.01% | 0.0% |
| Q3 2013 | $3,641,000 | -5.9% | 348,631 | +4.0% | 0.01% | -14.3% |
| Q2 2013 | $3,871,000 | – | 335,190 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |